IPP Bureau
NATCO invests US$ 2 million in Cellogen Therapeutics
By IPP Bureau - January 18, 2024
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Taro announces merger agreement with Sun Pharma
By IPP Bureau - January 18, 2024
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
Torque Pharma reinvents healthcare dynamics with 'Better Together'
By IPP Bureau - January 18, 2024
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
Indoco Remedies receives EIR from USFDA for Goa Plant-I
By IPP Bureau - January 18, 2024
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
Venus Remedies eceives GMP certification from Libya
By IPP Bureau - January 18, 2024
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
Dr. Agarwals Eye Hospital posts Q3 FY24 PAT at Rs. 9.44 Cr
By IPP Bureau - January 18, 2024
The company has posted net profit of Rs.33.57 crores for the 9 Months period ended December 31, 2023
Piramal Pharma launches new concentration of Zinc Sulfate for Injection in U.S.
By IPP Bureau - January 17, 2024
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
Alkem Labs reports 'fraudulent transfer' of Rs 52 Cr
By IPP Bureau - January 17, 2024
The company disclosed that several employees of a subsidiary had their business email addresses stolen
Agilent announces new ProteoAnalyzer system
By IPP Bureau - January 17, 2024
Automated parallel capillary electrophoresis system simplifies protein analysis
Parexel collaborates with Japanese Foundation for cancer research
By IPP Bureau - January 17, 2024
Collaboration streamlines patient access to oncology clinical trials
Tritan used for safer medical infusion therapy
By IPP Bureau - January 17, 2024
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
Bayer, Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India
By IPP Bureau - January 17, 2024
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
CuraTeQ Biologics receives recommendation for grant of marketing authorization of 'biosimilar trastuzumab'
By IPP Bureau - January 17, 2024
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
INVpack presents microdosing precision in pharma and nutritional packaging for India
By IPP Bureau - January 16, 2024
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets